Streetbeat News

Products Services

BMY

The European Commission has approved Bristol Myers Squibb's Opdivo (Nivolumab) in combination with Cisplatin and Gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This approval is based on the results from the CheckMate -901 Phase 3 trial, which demonstrated a survival benefit over standard-of-care chemotherapy alone.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:11 am

PMVP

Foundation Medicine and PMV Pharmaceuticals have partnered to develop a genomic profiling test as a companion diagnostic for PMV Pharma's investigational therapy, rezatapopt, targeting TP53 Y220C mutations in advanced cancers.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:10 am

TCRX

TScan Therapeutics announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its two lead TCR-T therapy candidates, TSC-100 and TSC-101, for the treatment of heme malignancies.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:05 am

MIST

The FDA has accepted Milestone Pharmaceuticals' New Drug Application for Cardamyst (Etripamil) nasal spray, aimed at managing paroxysmal supraventricular tachycardia. The Prescription Drug User Fee Act date is set for May 26, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:05 am

BABA

PDD

PDD Holdings Inc (NASDAQ:PDD) has surpassed Alibaba Group Holding Limited (NYSE:BABA) as China's most valuable e-commerce company, driven by the growth of its Temu marketplace. PDD's impressive first-quarter results, including a 246% surge in net income and a 327% increase in transaction services revenue, have boosted its market capitalization to $208 billion. Analysts project continued strength for PDD, while Alibaba focuses on diversifying its cloud computing business.

Portfolio Pulse from Anusuya Lahiri

May 29, 2024 | 11:01 am

ETN

PLTR

Eaton has expanded its partnership with Palantir Technologies to integrate Palantir's artificial intelligence platform into its operations. This collaboration aims to enhance Eaton's operational efficiency and data-driven decision-making capabilities.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 11:01 am

BA

Boeing's production slowdown of the 737 Max is causing significant disruptions in the aerospace supply chain, affecting suppliers and potentially leading to revenue losses. The Federal Aviation Administration has limited Boeing's production to 38 units per month, but the company is currently producing fewer. This situation is impacting Boeing's ability to meet airline demand and maintain industry stability.

Portfolio Pulse from Benzinga Neuro

May 29, 2024 | 11:01 am

ACM

AECOM has secured a five-year, multiple-award contract from the U.S. Army Environmental Command to provide environmental remediation services, including PFAS investigation and remediation, across various locations in the U.S., Puerto Rico, Hawaii, and Alaska. Financial terms were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 10:58 am

VFS

VinFast Auto Ltd. (NASDAQ: VFS) shares are trading slightly lower premarket as the company considers postponing its $4 billion factory in North Carolina due to challenges in appealing to American consumers. The factory, initially planned for completion in July 2024, was already delayed to 2025 and may face further delays. VinFast sold fewer than 1,000 cars in North America last year and is currently reviewing all aspects of the construction process.

Portfolio Pulse from Nabaparna Bhattacharya

May 29, 2024 | 10:51 am

AAP

During the sixteen weeks ended April 20, 2024, Advance Auto Parts (AAP) opened 7 stores and branches and closed 17, resulting in a total of 5,097 locations, down from 5,107 on December 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 10:43 am